Abstract
The primary endpoint of this trial was to assess clinical response (cCR) of squamocellular vulvar cancer (V-SCC) in elderly patients treated with electro-chemotherapy (ECT). Secondary endpoints were symptoms relief and local tumor control. A phase II study was designed and elderly patients with V-SCC unfit for other treatments were treated. Response Evaluation Criteria in Solid Tumors (RECIST criteria) were applied to evaluate tumor response. Quality of life (QoL) was evaluated by visual analogue score (VAS) for pain and four items of vulvar cancer subscale (VCS), of functional assessment of vulvar cancer therapy (FACT-V) [16], before, one month after the procedure and during follow-up. Median age was 85 years (range 66-96 years). One month after treatment complete response was observed in 13 patients (52%), partial response in 7 (28%), stable disease in 3 (12%), and progressive disease in 2 (8%). Local tumor control at 1 and 6 months was 91% and 53%, respectively. Symptom free survival at 1 and 6 months was 78% and 40%, respectively, with significant reduction of pain (P < 0.01). One-year overall survival was 34%. Our study showed that ECT produces high response rate with significant reduction of pain and improvement of local ...Continue Reading
References
Sep 1, 1991·Gynecologic Oncology·J S BerekN F Hacker
Apr 1, 1989·American Journal of Clinical Oncology·H B MussW A Christopherson
Aug 1, 1995·Gynecologic Oncology·B MillerD M Gershenson
May 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D.J. Sebag-MontefioreJ.H. Shepherd
Apr 1, 1961·Journal of Chronic Diseases·E A GEHAN
May 3, 2005·Gynecologic Oncology·Monika JandaMichael Trimmel
May 10, 2006·American Journal of Obstetrics and Gynecology·Wolfgang WeikelHeinz Koelbl
May 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine BouchardyGeorges Vlastos
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jun 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P O WitteveenN Reed
Jun 11, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Linda J RogersLynette A Denny
Nov 9, 2010·Dermatologic Therapy·Alessandro TestoriPier Francesco Ferrucci
Jun 19, 2012·Gynecologic Oncology·Zaid M TabbaaWilliam A Cliby
Dec 25, 2012·Archives of Gynecology and Obstetrics·Jacek J SznurkowskiJanusz Emerich
Jul 3, 2013·Gynecologic Oncology·Anna Myriam PerronePierandrea De Iaco
Mar 14, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·J A Rauh-HainM G del Carmen
May 23, 2014·Gynecologic Oncology·Kristina L Mirabeau-Beale, Akila N Viswanathan
Jun 7, 2014·Dermatologic Therapy·F RicottiA Offidani
Citations
Feb 18, 2016·Acta Oncologica·Antonio PellegrinoMaria Grazia Pezzotta
Jun 29, 2017·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Nicolò BizzarriPaolo Sala
Jun 8, 2018·Journal of Surgical Oncology·Anna M PerronePierandrea De Iaco
Dec 6, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Anastasios TranoulisRahul Nath
Jun 1, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Anna Myriam PerronePierandrea De Iaco
May 18, 2020·Cardiovascular and Interventional Radiology·F AndrescianiR F Grasso
May 7, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giacomo CorradoGiorgia Garganese
May 15, 2019·Cancers·Anna Myriam PerronePierandrea De Iaco
Jul 11, 2018·Technology in Cancer Research & Treatment·Ute ProbstPhilipp Wiggermann
Apr 21, 2021·Technology in Cancer Research & Treatment·Sebastjan MerloNina Kovačević
May 1, 2021·Cancers·Anna Myriam PerronePierandrea De Iaco
May 1, 2021·Cancers·Anna Myriam PerronePierandrea De Iaco